Deficient antibiotic production in an afsB mutant, BH5, of Streptomyces coelicolor A3(2) was recently shown to be due to a mutation (G243D) in region 1.2 of the primary sigma factor s HrdB .
INTRODUCTION
Since bacteria contain only one type of core RNA polymerase, sigma factors play a critical role in directing gene transcription. In Streptomyces coelicolor A3(2), 65 genes are predicted to encode sigma factors (Bentley et al., 2002) . Among these are four highly homologous genes, hrdA, hrdB, hrdC and hrdD, which encode sigma factors belonging to the s 70 family, the principal sigma factor in Escherichia coli. Disruption of the hrdB gene was shown to be lethal, whereas inactivation of other hrd genes had no effects, indicating that hrdB encodes the principal and essential sigma factor in S. coelicolor A3(2) (Brown et al., 1992; Buttner & Lewis, 1992; Buttner et al., 1990) . In vivo, s HrdB recognizes the promoters of actII-ORF4 and redD (Fujii et al., 1996) , the pathway-specific regulatory genes for actinorhodin (Act) and undecylprodigiosin (Red), respectively (Gramajo et al., 1993; Takano et al., 1992) .
The bacterial alarmone guanosine tetraphosphate (ppGpp), the critical mediator in the stringent response, is synthesized under conditions of nutrient limitation and binds to the bsubunit of RNA polymerase (RNAP) (Artsimovitch et al., 2004; Chatterji et al., 1998) , triggering the initiation of antibiotic production (Bibb, 2005; Ochi, 2007) . Increased intracellular ppGpp concentration causes precocious and enhanced antibiotic production Saito et al., 2006; Sun et al., 2001) , while some relaxed mutants (relA and relC), which are unable to synthesize ppGpp or are impaired in its synthesis, were deficient in antibiotic production (Chakraburtty & Bibb, 1997; Ochi, 1987 Ochi, , 1990a Ochi et al., 1997) . Forced induction of ppGpp synthesis in S. coelicolor A3(2), even under nutrient-rich conditions, can elicit antibiotic production , thus demonstrating the essential role of ppGpp in activation of antibiotic production. We have found that certain rifampicinresistance (rif) mutations in the b-subunit of RNAP are able to restore antibiotic production in a ppGpp-impaired background Saito et al., 2006; Xu et al., 2002) . It was conceivable that these rif mutations bypassed the requirement of ppGpp for the transcription of regulatory genes of antibiotic production (Ochi, 2007) .
Studies on mutations that enhance or abolish antibiotic production have enabled the investigation of the complex regulatory network underlying antibiotic production in Streptomyces spp. S. coelicolor A3(2) afsB mutant BH5, which was originally isolated by its inability to produce an A-factor-like activity, was conditionally deficient in antibiotic production (Aigle et al., 2000; Hara et al., 1983) . Exogenous supplementation with diffusible signalling molecule SCB1, however, failed to restore antibiotic production (Aigle et al., 2000) . The afsB mutation was shown by Aigle et al. (2000) to consist of a G243D substitution in the conserved region 1.2 of principal sigma factor s HrdB . However, the reason why a mutation in the principal sigma factor pleiotropically abolished antibiotic production was not clear. Here, we report that the afsB mutant BH5 is characterized by a lower intracellular ppGpp level, which underlies the deficient antibiotic production by this mutant strain.
METHODS
Bacterial strains and cultivation conditions. The strains used in this study were S. coelicolor A3(2) wild-type strains 1147 (Kieser et al., 2000) , A700 (argA1 proA1 cysD18) (Kieser et al., 2000) and its afsB mutant BH5 (Hara et al., 1983) , and M145 (Kieser et al., 2000) and its hrdB gene replacement strain M760 (Aigle et al., 2000) . All strains were grown at 30 uC on various agar media, including GYM (Shima et al., 1996) , R4 (Shima et al., 1996) , R5
2 (R5 medium minus KH 2 PO 4 , CaCl 2 and proline) (Huang et al., 2001) , SMMS (Kieser et al., 2000) , R2YE (Kieser et al., 2000) and SFM media (Kieser et al., 2000) or in liquid SMM (Kieser et al., 2000) and YEME media (Kieser et al., 2000) . Amino acids were supplemented with 100 mg proline ml
21
, 100 mg arginine ml 21 and 30 mg cysteine ml 21 when needed. Spontaneous drug-resistant mutants were obtained from colonies that grew within 7 days after spores were spread onto GYM plates containing rifampicin (100 or 200 mg ml
) or thiostrepton (3 or 15 mg ml
). All mutants were used for further studies after single colony isolation. Mutations in the rpoB gene were determined by DNA sequencing, as described previously . Primers rel-F (59-CGCCTGCACAACATGCGCACCATGCG-39) and rel-R (59-GGTCTCCTTCTGCCAGTCGAGCAGC-39), and RT-F (59-CAGGTC-GGCGAGCAGTTC-39) and RT-R (59-GTCGACCTTCTCCAGCTT-GGT-39) were used for amplification and DNA sequencing of relA and rshA, respectively.
Determination of MICs and antibiotic production. The minimum inhibitory concentrations (MICs) were determined as previously described (Wang et al., 2008) . Act production on plates was assessed directly by the intensity of the blue colour. Production of Act and Red in liquid media was determined as described by Kieser et al. (2000) .
Gene replacement of rpoB allele. A~3.1 kb truncated rpoB gene fragment lacking 480 bp of the N-terminal region was amplified with primers rpoB-F1 (59-CGTGTCGTCGTGTCGCAGCTG-39) and rpoB-R (59-GTTTCAGACCACAGACTTACAAGGGTGAG-39) using total DNA of a rifampicin-resistant mutant, Rif20 (H437Y), as the template. PCR product was cloned into pKK1000, a plasmid unable to replicate in Streptomyces , yielding pKK-HY, which was used to transform the afsB mutant BH5, as described by Kieser et al. (2000) . Since pKK-HY was presumed to integrate into the chromosome at the rpoB locus, transformants were selected with apramycin resistance. To allow the loss of plasmid on another homologous recombination, two transformants were grown non-selectively on R5 2 plates for three successive rounds, serial dilutions of the resulting spores were plated, and colonies sensitive to apramycin were selected. Replacement of wild-type rpoB by the rifampicin-resistance mutant allele was confirmed by PCR and DNA sequencing.
Disruption of relA. To disrupt the relA gene, total DNA of a relA null mutant, M570, in which most of the relA gene (corresponding to amino acid residues 167 to 683 of 847 residues) had been replaced by a hygromycin-resistance gene (Chakraburtty & Bibb, 1997) , was used directly for transformation. Immediately after treatment with alkali, approximately 3 mg of total DNA was used to transform protoplasts of rifampicin-resistant mutants Rif16 (H437R) and Rif20 (H437Y), or the thiostrepton-resistant mutant Tsp33, as described by Kieser et al. (2000) . Transformants were selected for hygromycin resistance. Disruption of the relA gene was confirmed by PCR for the absence of the internal relA region and for the presence of the hygromycin-resistance gene.
Conjugation procedure. Conjugation-based gene transfer between S. coelicolor strains was performed as described by Kieser et al. (2000) . For the transfer of the thiostrepton-resistance mutation between strain Tsp33 and the prototrophic wild-type 1147, conjugants were selected for thiostrepton resistance and the absence of auxotrophy (argA1 proA1 cysD18). The presence of the wild-type hrdB gene was confirmed by DNA sequencing. To introduce the relA null mutation into the thiostrepton-resistant mutant Tsp33, conjugants were selected for both thiostrepton and hygromycin resistances, as well as the presence of auxotrophy. The presence of the afsB mutation in the hrdB gene was confirmed by DNA sequencing.
RNA isolation and real-time quantitative PCR (RT-qPCR)
analysis. Total RNA was prepared from cells grown in liquid culture or on agar plates covered with cellophane sheets as described by Wang et al. (2008) . Following incubation with RNase-free DNase I (Invitrogen), 1 mg of each total RNA sample was reverse transcribed, using the Thermoscript RT-PCR system (Invitrogen) and random hexamers, as described by the manufacturer. RT-qPCR was performed using a 7300 real-time PCR system and Power SYBR Green PCR Master Mix (Applied Biosystems) as described by Wang et al. (2008) . Transcription of the 16S rRNA gene was used as an internal control. Each transcriptional assay was normalized to the corresponding transcriptional level of 16S rRNA. The primers used were orf4-F2 (59-TGATCGACGAGGACGAACTCG-39) and orf4-R1 (59-ATTCG-CGTCGATACGGACCTG-39) for actII-ORF4; redD-F1 (59-AAAGT-GCTCAACGAGCGTGCCTGC-39) and redD-R (59-GAACATCGC-GCTGATGAGATCCTCC-39) for redD; rel-F and rel-R for relA; and 16S-F1 (59-GCGATAGCCTGATGCAGCGACG-39) and 16S-R (59-GCGCATTTCACCGCTACACCAGG-39) for the 16S rRNA gene.
Assay of ppGpp. Intracellular ppGpp was extracted from cells grown on agar plates covered with cellophane sheets using 1 M formic acid and quantified by HPLC (Ochi, 1987) . For nutritional shift-down, exponentially growing cells in chemically defined (CD) medium (Okamoto-Hosoya et al., 2003) supplemented with 3 % (w/v) Casamino Acids (vitamin free, Difco) were filtered with filter paper (Whatman no. 2) and rapidly transferred to fresh CD medium without Casamino Acids. At 15, 30, 45 and 60 min after nutritional shift-down, cells were harvested by filtration; ppGpp was immediately extracted using 1 M formic acid. Each ppGpp pool size was expressed as pmol (mg dry weight) 21 .
RESULTS
Isolation of rifampicin-resistance mutations able to restore antibiotic production in the afsB mutant BH5
The afsB mutant BH5 was conditionally deficient in antibiotic production. Although BH5 produces Act as much as the wild-type strain on phosphate-limited media (Aigle et al., 2000 ; see also Supplementary Fig. S1 , available with the online version of this paper), it failed to produce Act and Red on nitrogen-limited SMMS plates. We found that R5 2 medium gave rise to a better differentiation than SMMS medium for Act production between BH5 and wildtype strain A700, although they produced similar amounts of Red (Fig. 1a) . Our laboratory has shown that certain rif mutations in the RNAP b-subunit were able to activate Act production in various Streptomyces strains (Hosaka et al., 2009; Hu et al., 2002; Lai et al., 2002; Saito et al., 2006; Tala et al., 2009; Wang et al., 2008; Xu et al., 2002) . In afsB mutant BH5, some spontaneous rif mutants, which were able to restore Act production, arose on GYM plates containing various concentrations of rifampicin. Since most rif mutations reported to date were located in the socalled rif cluster I of the rpoB gene, which encodes the RNAP b-subunit, rpoB genes of over 80 rif mutants were sequenced. As expected, most of the rif isolates harboured mutations in rif cluster I (Table 1) . Among the rif mutations analysed, S433L, S433P, H437R and H437Y were able to restore Act production on R5 2 plates ( Fig. 1a ; Table 1 ), and also Red production as checked in liquid SMM medium (Fig. 2a) . Other rif mutations, including D427A, D427G and H437N, did not show restoration of Act production, whereas the H437Q and R440C mutations effectively restored Red production only (Table 1, Fig 2a) .
The transcription of pathway-specific positive regulatory genes, actII-ORF4 and redD, was severely reduced in the afsB mutant BH5 (Aigle et al., 2000) . As shown by RT-qPCR (Fig. 1b and Fig. 2b) , transcription of actII-ORF4 and redD was restored in the rif mutants, which accounts for the restoration of antibiotic production.
Since BH5 was obtained by chemical mutagenesis of A700, it may contain additional mutations. To analyse restoration of antibiotic production by rif mutations in a clearer genetic background, M760, a hrdB gene replacement strain of wild-type strain M145 (Aigle et al., 2000) , was used to develop rif mutants. Similar restoration of Act production in M760 by the same rif mutations was observed (Fig. 1c) . To demonstrate a causal role of rif mutations in restoring antibiotic production, we used Rif20 (H437Y) as a representative to perform gene replacement experiments to replace the wild-type rpoB allele of BH5 by a mutant rpoB allele (H437Y) of Rif20 via homologous recombination (see Methods). The recombinant strains, which contained a mutant rpoB allele, produced Act as well as the wild-type strain A700, while a negative control containing a wild-type allele of rpoB did not (Fig. 3) , indicating that the rpoB H437Y mutation was responsible for the restoration of antibiotic production.
The afsB mutation affects ppGpp pool size Our previous studies have shown that Act production in mutants relA, relC and eshA, in which ppGpp synthesis was deficient or impaired, can be restored by introduction of certain rifampicin-resistance mutations Saito et al., 2006; Xu et al., 2002) . The restoration of antibiotic production by rif mutations was proved to be ppGpp-independent Xu et al., 2002) . It was conceivable that rif mutations in the RNAP b-subunit bypassed the requirement of ppGpp for the activation of antibiotic production. Similarly, disruption of the relA gene did not abolish Act production in the afsB rif strains Rif16 (H437R) and Rif20 (H437Y) (Supplementary Fig. S2 ).
These results suggested that the afsB mutant BH5 might have an impaired synthesis of ppGpp. To test this hypothesis, we analysed the intracellular ppGpp pool size of strain BH5 and its parental strain A700. Strikingly, the ppGpp pool size of BH5 was lower than that of A700 throughout the entire growth phase when the strains were grown on SMMS agar plates (Fig. 4a) . A lower level of ppGpp was also observed in the hrdB gene replacement strain M760 than its parental strain M145, as examined using SMMS and R5 2 agar plates (Fig. 4b) . To further characterize the afsB mutation, we analysed the ability of these strains to synthesize ppGpp upon nutritional shiftdown (see Methods). We found that the afsB mutant BH5 has a much lower ability to synthesize ppGpp upon nutritional shift-down (Fig. 5) . These results indicate that the afsB (5hrdB) mutation results, directly or indirectly, in the impaired accumulation of ppGpp in growing cells, although the observed reduction in ppGpp pool size was rather small.
Certain thiostrepton-resistance mutations circumvent afsB mutation
We have reported previously that introduction of certain mutations (tsp), which confer a moderate level of resistance to thiostrepton, markedly enhances the intracellular accumulation of ppGpp in S. coelicolor A3(2) (Wang et al., 2008) . We therefore hypothesized that these tsp mutations may circumvent the effect of the afsB mutation on antibiotic production by enhancing the ppGpp synthesis. Spontaneous resistant colonies that developed after spreading BH5 spores onto GYM plates containing thiostrepton were tested for Act production and thiostrepton resistance. Among 250 colonies resistant to thiostrepton, two isolates, Tsp33 and Tsp38 (Table 2) , were found to produce Act as well as the afsB + wild-type strain A700 (Fig. 6a) . Red production was also restored in these tsp mutants (Fig. 6b) . Tsp33 (tsp-33) was used for further study because of its higher level of resistance to thiostrepton.
Tsp33 (and Tsp38) had no mutations in the rplK gene, which encodes the ribosomal protein L11, although thiostrepton resistance is often due to a mutation in the rplK gene; and most tsp mutations in rplK decrease antibiotic production (Ochi, 1987 (Ochi, , 1990b Ochi et al., 1997) . We also found that these tsp mutants had no mutations in the relA and rshA [a homologue of relA with 42 % identity ] genes. Further attempts, such as genetic mapping and comparative genome sequencing analysis (Nishimura et al., 2007) , failed to identify the tsp-33 mutation of Tsp33.
To confirm the essential role of the tsp mutation in the restoration of antibiotic production, we conducted conjugation experiments between prototrophic wild-type 1147 and tsp mutant Tsp33. Conjugants were selected for their resistance to thiostrepton and the absence of auxotrophy carried by BH5. All thiostrepton-resistant conjugants Fig. 3 . Act production in the rpoB replacement strains. Gene replacement of wild-type rpoB in BH5 by a mutant copy of rpoB (H437Y) was performed as described in Methods. Strains were grown at 30 6C for 4 days on GYM or R4 agar plates. The reverse side of the plate was photographed to show the blue-coloured antibiotic Act.
produced an increased amount of Act (e.g. Fig. 6c for the conjugant 1147tsp-c), indicating that the tsp-33 mutation was a cause of activation of Act production.
ppGpp is crucial for the restoration of Act production in Tsp33
We investigated the intracellular levels of ppGpp in Tsp33 growing on GYM plates. As expected, Tsp33 accumulated significantly high levels of ppGpp throughout the entire growth phase. This was especially pronounced during the early growth phase, in that the ppGpp level was 5-10-fold higher in Tsp33 than in its parental strain BH5 or wild-type strain A700 (Fig. 7a) . The enhanced accumulation of ppGpp was detected also in the conjugant 1147tsp-c (data not shown). Moreover, following nutritional shift-down, Tsp33 accumulated threefold more ppGpp than did BH5 (Fig. 5 ), indicating that Tsp33 had regained the ability to synthesize and accumulate ppGpp. To dissect the mechanism underlying the enhanced accumulation of ppGpp, we performed RT-qPCR analysis of the relA gene. We found that the relA expression level during the early growth phase (15-25 h) was lower in Tsp33 than in its parental strain BH5 (Fig. 7b ). Conversely, relA expression level during the late growth phase (45-55 h) was high (Fig.  7b) , despite the low ppGpp pool size at this growth phase (Fig. 7a) . Thus, enhanced ppGpp accumulation in Tsp33 during the early growth phase was not due to transcription of the relA gene.
To confirm that tsp mutation restored antibiotic production via regaining the synthesis and accumulation of ppGpp, we again abolished ppGpp synthesis in Tsp33 by disrupting the relA gene using gene replacement or conjugation ( Table 2 ). Disruption of relA in Tsp33 resulted in a total loss of ppGpp synthesis [less than the detectable level of 0.1 pmol (mg dry weight) 21 ], accompanied by a complete abolition of Act production (Fig. 6a) . These results clearly demonstrate that an increased level of ppGpp was crucial for the restoration of antibiotic production in Tsp33.
DISCUSSION
The stringent response, a general and ubiquitous response to nutrient limitation in prokaryotes which plays a central role in responding to nutrient stress, mediates its effect through the bacterial alarmone ppGpp (Braeken et al., 2006; Cashel et al., 1996) . We show here that unimpaired functions of the principal sigma factor s HrdB are essential in establishing an intracellular level of ppGpp sufficient to trigger antibiotic production in S. coelicolor A3(2), at least under some nutrient conditions. In other words, the intracellular level of ppGpp is finely tuned to successfully trigger antibiotic production in the wild-type strain. This fine tuning, however, is absent from the afsB mutant BH5, which possesses a mutation in s HrdB , thus leading to failed initiation of antibiotic production. This suggests that a threshold level of ppGpp is required to trigger antibiotic production and that relatively small differences in ppGpp pool sizes result in dramatic changes in antibiotic production. This conclusion harmonizes well with our Modulation of ppGpp level by an afsB mutation previous conclusions derived from studies analysing the function of the EshA protein, which accentuates ppGpp accumulation and is conditionally required for antibiotic production in S. coelicolor A3(2) and Streptomyces griseus (Saito et al., 2006) . The mechanism by which a mutation in the primary sigma factor affects ppGpp synthesis, however, remains unclear. The fact that hrdB is the major sigma factor required for vegetative growth in S. coelicolor A3(2), and point mutations in it are therefore likely to have significant pleiotropic effects on gene expression, makes it difficult to define exactly what is happening under the conditions used in this study. This is further complicated by the known pleiotroptic effects of ppGpp on gene expression in S. coelicolor A3(2) (Hesketh et al., 2007) . However, it is most likely that the metabolic disturbance (e.g. curtailment of substrates for ppGpp synthesis) caused by a mutation in the primary sigma factor eventually resulted in a reduced level of intracellular ppGpp.
The afsB mutant BH5 shows a striking phenotypic similarity with the relA mutant, in that both are deficient in Act and Red production but retain normal ability to produce the antibiotic CDA (Aigle et al., 2000) and that both display delayed aerial mycelium development. Regaining of antibiotic productivity by introduction of rif (5rpoB) mutations or by cultivation in phosphate-limiting media is also a common characteristic in relA and afsB mutants ; this study). Our present study accounts well for the observed phenotypic similarities in the framework of the ability to synthesize and accumulate ppGpp, and more importantly, may indicate a new strategy to activate dormant gene expression in bacteria, as actually demonstrated in soil-isolated actinomycetes (Hosaka et al., 2009) .
Thiostrepton resistance (tsp) mutations in the rplK gene, conferring a high level of resistance to thiostrepton, have been shown to result in a decrease in the bacterial ability to synthesize ppGpp (Kasai et al., 2006; Ochi, 1987 Ochi, , 1990a Ochi et al., 1997; Wendrich et al., 2002;  and as listed in reference Ochi, 2007) . The thiostrepton-resistance mutations (tsp-33 and tsp-38) utilized in this study, however, are characterized by a peculiar phenotype. These tsp mutations were not located in the rplK gene and the presence of a tsp mutation led to the cellular accumulation of aberrant levels of ppGpp (Fig. 7a) , resulting in the complete restoration of antibiotic production in the afsB mutant (Fig. 6a, b) . These findings, together with other recent results (Wang et al., 2008) , are the first to demonstrate the existence of a new class of tsp mutations that cause an increase in ppGpp levels. Disruption of relA in Tsp33 led to loss of ppGpp synthesis, whereas the accumulation of ppGpp was not affected by transcription of relA (Fig. 7b) . Although the detailed molecular mechanisms underlying these phenomena, in addition to the mutated gene in the tsp mutants, are not yet known, the remarkable overproduction of antibiotic caused by introducing this class of tsp mutation (Fig.  6c) demonstrates that the latter can be used for strain improvement.
